Related Experiment Videos
[Treatment with beta blockers in advanced heart failure]
E Gronda1, A Bologna, M Mangiavacchi
1Unità di Cardiologia Clinica e di Terapia dell'Insufficienza Cardiaca, Istituto Clinico Humanitas, Rozzano.
Summary
Beta-blocker therapy can improve heart function and reverse remodeling in heart failure patients. Despite reduced tolerability in severe cases, careful management allows most patients to benefit from improved symptoms and survival.
Area of Science:
- Cardiology
- Pharmacology
Context:
- Sympathetic nervous system activation exacerbates heart failure progression.
- Advanced heart failure patients often remain symptomatic despite optimal ACE-inhibitor therapy.
Purpose:
- To review clinical experience with beta-blockers in advanced heart failure.
- To discuss optimal initiation and titration strategies for beta-blocker therapy.
- To evaluate prognostic parameters for tolerability and efficacy.
Summary:
- Beta-blockers improve ventricular function and can reverse cardiac remodeling in heart failure.
- While tolerability is reduced in severe heart failure, careful monitoring and titration enable successful treatment.
- Patients with advanced heart failure may experience significant symptomatic and survival benefits from beta-blocker therapy.
Impact:
- Beta-blocker therapy offers a viable treatment option for improving outcomes in advanced heart failure.
- Optimized drug initiation and titration protocols enhance beta-blocker tolerability and efficacy.
- Prognostic parameter evaluation aids in personalized treatment strategies for heart failure patients.